Sleep

Pain

  • Cannabis Edibles for Arthritis · Where the gap between CBD marketing and CBD evidence is widest: the human trials are null, and the one positive arthritis trial used THC.
  • Cannabis Edibles for Chronic Pain · Pain is the strongest single indication in the cannabis-medicine literature. The protocol depends on which of four pain mechanisms is producing the symptoms.
  • Cannabis Edibles for Endometriosis Pain · A mixed-mechanism women's-health pain condition with a consistent observational base now being confirmed by longitudinal registry and controlled-trial data.
  • Cannabis Edibles for Fibromyalgia · The canonical nociplastic pain condition, with the most developed cannabinoid mechanism story in chronic pain and a CBD-leaning protocol.
  • Cannabis Edibles for Lower Back Pain · The world's leading cause of disability, and the condition that produced the first phase 3 RCT win for an oral cannabis extract, the format that maps onto edibles.
  • Cannabis Edibles for Menstrual Cramps · One of the most normalized pain conditions in medicine, with an unusually clean dual mechanism: THC relaxes the uterine muscle, CBD blocks the prostaglandin pathway ibuprofen targets.
  • Cannabis Edibles for Migraine · A mixed-mechanism condition where cannabis has its best evidence for acute attacks, weaker evidence for prevention, and a real medication-overuse-headache risk.
  • Cannabis Edibles for Neuropathic Pain · The strongest randomized-trial base of any pain type, with the honest caveat that most trials used inhaled or oromucosal cannabis rather than edibles.
  • Cannabis Edibles for Post-Surgical Pain · The Pain cluster page where the answer is mostly no: thin, contradictory acute evidence, and observational data suggesting regular users have more post-op pain, not less.

Anxiety and Mood

  • Cannabis Edibles for Comorbid Depression · The largest meta-analysis of cannabinoid trials found zero controlled trials for depression. The only defensible case is second-order: treat the comorbid pain, insomnia, or anxiety and watch whether mood follows.
  • Cannabis Edibles for Generalized Anxiety · The condition where dose decides whether cannabis helps or hurts: 7.5mg of THC reduced stress in trial, 12.5mg increased it.
  • Cannabis Edibles for Panic Disorder · The condition where THC is closest to a contraindication: its acute effects reproduce panic symptoms almost exactly, and ED data shows edibles are the product most often responsible.
  • Cannabis Edibles for PTSD · The widest gap in cannabis medicine between how much it is used and how little supports it: the largest analysis of randomized trials found no benefit for PTSD symptoms.
  • Cannabis Edibles for Social Anxiety · The strongest CBD case in the anxiety cluster and the sharpest anti-THC case, with newer evidence favouring sustained daily dosing over pre-event dosing.
  • Seasonal Affective Disorder · Why THC is pharmacologically backwards for winter depression, and the two narrow cases where an edible is defensible.

Psychiatric

  • Cannabis Edibles and Bipolar Disorder · Cannabis goes with about three times the odds of new manic symptoms, quitting a nightly gummy costs sleep within days, and the one CBD trial in bipolar depression missed its primary outcome. Why lithium and lamotrigine win the comparison on evidence.
  • Cannabis Edibles and Psychosis Risk · The best-documented harm in cannabis medicine, and the one no US label mentions. Who should never take THC, why 1:1 gummies do not protect you, and why the CBD that worked in trials is forty times a retail dose.
  • Cannabis Edibles and Schizophrenia · The one controlled test of CBD as THC's "balance" in people with schizophrenia made memory and psychotic symptoms worse. What the 300 to 1,000 mg treatment trials found, why the 2026 reviews split, and why swapping joints for edibles on clozapine is a medication event.

Oncology

  • Cannabis Edibles for Cancer Cachexia · The condition where the munchies intuition was tested at scale and failed: cachexia is metabolic wasting rather than an appetite deficit, and the honest role for edibles is taste and comfort.
  • Cannabis Edibles for Chemotherapy-Induced Nausea · The strongest evidence in cannabis medicine: a 2024 phase III trial where 2.5mg THC with matched CBD tripled complete response in patients failing modern antiemetics.
  • Cannabis Edibles for Radiation-Induced Nausea · Three small trials from the mid-1980s, all run before ondansetron existed: why everything here is borrowed from the chemotherapy evidence, and how to borrow it with the least risk.
  • Edibles for Cancer-Related Anxiety · The largest placebo-controlled CBD trial in advanced cancer found no benefit over placebo. Why CBD-first still holds on safety grounds, where THC flips against you, and the tamoxifen conversation that comes before any purchase.
  • Edibles for Cancer-Related Pain · A positive phase 2, a dose-finding trial pointing at low doses, and a phase 3 program that failed: cannabinoids as a low-dose adjunct to opioid therapy, never a replacement.
  • Edibles for Insomnia During Cancer Treatment · Treatment insomnia is usually a symptom with a findable cause, often dexamethasone. Where CBN and low-dose THC genuinely fit, and the steroid-timing conversation that beats any product.

Neurological

  • Cannabis Edibles for Cluster Headache · The one headache where an edible is the wrong tool for the attack. An untreated attack lasts 15 to 180 minutes and a gummy takes 30 to 90 to start, the patient surveys split three ways, and the verapamil most patients take already needs its own ECG.
  • Cannabis Edibles for Multiple Sclerosis Spasticity · Cannabinoids keep failing the neurologist's ruler and passing the patient's. The strongest trial evidence for any cannabis medicine on this site, a titration schedule borrowed from the oral trials, and the NHS stop rule: if your own 0 to 10 rating has not dropped 20% in four weeks, stop.
  • Cannabis Edibles for Tourette Syndrome · One of the few conditions where the best cannabis trials were swallowed. A slowly titrated 1:1 THC:CBD oral product has the strongest small-trial support for severe adult tics, the largest trial missed its primary endpoint, and the evidence in children is case reports.
  • Cannabis Edibles for Trigeminal Neuralgia · The wrong shape for an edible: attacks last seconds and a gummy takes 30 minutes to 2 hours. Two case reports, carbamazepine speeding THC out of the body, and why the picks are a mint and a drink when chewing sets off the pain.

Women's Health

  • Cannabis Edibles and Postpartum Recovery · The one Women's Health page that asks whether, not which. For anyone breastfeeding, ACOG, the AAP, and LactMed say no: THC has been found in milk from six days to more than six weeks after last use, pump and dump does nothing about it, and no trial has tested an edible in this population.
  • Cannabis Edibles for Dysmenorrhea · The clinical word for period pain, and the diagnosis matters more than the gummy. NSAIDs have 80 trials behind them, THC relaxes uterine muscle only in a dish so far, and an edible is the floor under the worst day for the reader whose ibuprofen falls short.
  • Cannabis Edibles for Menopause · Menopause is five problems wearing one name. Sleep responds best, mood and joint pain have a borrowed case, and hot flashes have almost no evidence at all: the symptom-by-symptom umbrella for the Women's Health cluster.
  • Cannabis Edibles for PCOS-Related Pain · PCOS pain gets treated online as period pain under another name. Irregular cycles break the pre-dosing protocol, insulin resistance changes what a sugar-loaded gummy costs you, and anyone trying to conceive has a reason to leave THC out.
  • Cannabis Edibles for Perimenopause Anxiety · Perimenopause manufactures anxiety in women who never had it. CBD has small but consistent observational support at gummy-sized doses, THC belongs at 2.5mg or nowhere, and most menopause gummies get the arithmetic backwards.

Other

  • Cannabis Edibles for Crohn's Disease · The best cannabis trial result in Crohn's came from a 115mg THC cigarette. Oral cannabis moved symptom scores and left endoscopy, CRP and calprotectin alone, CBD at prescription doses causes diarrhoea, and the edible sits beside the biologic.

New condition pages publish monthly. Request one at hello@ediblerank.com.